메뉴 건너뛰기




Volumn 7, Issue 10, 2012, Pages

Beneficial Effect of Antibodies against β- Secretase Cleavage Site of App on Alzheimer's-Like Pathology in Triple-Transgenic Mice

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; BETA SECRETASE; GLYCOGEN SYNTHASE KINASE 3BETA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BBS1; TAU PROTEIN; UNCLASSIFIED DRUG;

EID: 84867370380     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046650     Document Type: Article
Times cited : (17)

References (52)
  • 1
    • 0034962780 scopus 로고    scopus 로고
    • Natural history of Alzheimer's disease
    • Honig LS, Mayeux R, (2001) Natural history of Alzheimer's disease. Aging 13: 171-182.
    • (2001) Aging , vol.13 , pp. 171-182
    • Honig, L.S.1    Mayeux, R.2
  • 2
    • 0030806911 scopus 로고    scopus 로고
    • Brain infarction and the clinical expression of Alzheimer disease
    • Roman GC, (1997) Brain infarction and the clinical expression of Alzheimer disease. JAMA. 9 278(2): 113-4.
    • (1997) JAMA , vol.278 , Issue.2 , pp. 113-114
    • Roman, G.C.1
  • 3
    • 63849176138 scopus 로고    scopus 로고
    • The role of tau in neurodegeneration
    • Gendron TF, Petrucelli L, (2009) The role of tau in neurodegeneration. Mol Neurodegener. 11 4: 13.
    • (2009) Mol Neurodegener , vol.11 , Issue.4 , pp. 13
    • Gendron, T.F.1    Petrucelli, L.2
  • 4
    • 0027420369 scopus 로고
    • Tau protein and the neurofibrillary pathology of Alzheimer's disease
    • Goedert M, (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends in Neurosciences. 16 11: 460-465.
    • (1993) Trends in Neurosciences , vol.16 , Issue.11 , pp. 460-465
    • Goedert, M.1
  • 6
    • 37749047236 scopus 로고    scopus 로고
    • Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?
    • Muyllaert D, Kremer A, Jaworski T, Borghgraef P, Devijver H, et al. (2008) Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology? Genes Brain Behav. 7 (Suppl 1): 57-66.
    • (2008) Genes Brain Behav , vol.7 , Issue.SUPPL. 1 , pp. 57-66
    • Muyllaert, D.1    Kremer, A.2    Jaworski, T.3    Borghgraef, P.4    Devijver, H.5
  • 7
    • 21044449225 scopus 로고    scopus 로고
    • Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo
    • Noble W, Planel E, Zehr C, Olm V, Meyerson J, et al. (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci U S A 10 102(19): 6990-5.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , Issue.19 , pp. 6990-6995
    • Noble, W.1    Planel, E.2    Zehr, C.3    Olm, V.4    Meyerson, J.5
  • 8
    • 34250818767 scopus 로고    scopus 로고
    • Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles
    • Caccamo A, Oddo S, Tran LX, LaFerla FM, (2007) Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. Am J Pathol. 170(5): 1669-75.
    • (2007) Am J Pathol , vol.170 , Issue.5 , pp. 1669-1675
    • Caccamo, A.1    Oddo, S.2    Tran, L.X.3    LaFerla, F.M.4
  • 9
    • 0035066332 scopus 로고    scopus 로고
    • Alzheimer's disease: genes, proteins, and therapy
    • Selkoe DJ, (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 81(2): 741-66.
    • (2001) Physiol Rev , vol.81 , Issue.2 , pp. 741-766
    • Selkoe, D.J.1
  • 11
    • 0037010298 scopus 로고    scopus 로고
    • Beta-secretase as a target for the treatment of Alzheimer's disease
    • Citron M, (2002) Beta-secretase as a target for the treatment of Alzheimer's disease. J Neurosci Res. 70: 373-9.
    • (2002) J Neurosci Res , vol.70 , pp. 373-379
    • Citron, M.1
  • 12
    • 0035112647 scopus 로고    scopus 로고
    • BACE1 is the major beta-secretase for generation of Abeta peptides by neurons
    • Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, et al. (2001) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci. 4: 233-4.
    • (2001) Nat Neurosci , vol.4 , pp. 233-234
    • Cai, H.1    Wang, Y.2    McCarthy, D.3    Wen, H.4    Borchelt, D.R.5
  • 13
    • 0036861132 scopus 로고    scopus 로고
    • Emerging Alzheimer's disease therapies: inhibition of beta-secretase
    • Citron M, (2002) Emerging Alzheimer's disease therapies: inhibition of beta-secretase. Neurobiol Aging. 23(6): 1017-22.
    • (2002) Neurobiol Aging , vol.23 , Issue.6 , pp. 1017-1022
    • Citron, M.1
  • 14
    • 77954051527 scopus 로고    scopus 로고
    • Identification of beta-secretase (BACE1) substrates using quantitative proteomics
    • Hemming ML, Elias JE, Gygi SP, Selkoe DJ, (2009) Identification of beta-secretase (BACE1) substrates using quantitative proteomics. PLoS One. 29 4(12): e8477.
    • (2009) PLoS One , vol.4 , Issue.12
    • Hemming, M.L.1    Elias, J.E.2    Gygi, S.P.3    Selkoe, D.J.4
  • 15
    • 19644368873 scopus 로고    scopus 로고
    • Inhibition of amyloid precursor protein processing by beta-secretase through site-directed antibodies
    • Arbel M, Yacoby I, Solomon B, (2005) Inhibition of amyloid precursor protein processing by beta-secretase through site-directed antibodies. Proc Natl Acad Sci USA 102: 7718-7723.
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 7718-7723
    • Arbel, M.1    Yacoby, I.2    Solomon, B.3
  • 16
    • 34547215215 scopus 로고    scopus 로고
    • Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels
    • Rakover I, Arbel M, Solomon B, (2007) Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels. Neurodegener Dis. 4(5): 392-402.
    • (2007) Neurodegener Dis , vol.4 , Issue.5 , pp. 392-402
    • Rakover, I.1    Arbel, M.2    Solomon, B.3
  • 17
    • 78650825703 scopus 로고    scopus 로고
    • Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice
    • Arbel-Ornath M, Becker M, Rabinovich-Toidman P, Gartner M, Solomon B, (2010) Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice. J Alzheimers Dis. 22(2): 469-82.
    • (2010) J Alzheimers Dis , vol.22 , Issue.2 , pp. 469-482
    • Arbel-Ornath, M.1    Becker, M.2    Rabinovich-Toidman, P.3    Gartner, M.4    Solomon, B.5
  • 18
    • 0036468268 scopus 로고    scopus 로고
    • Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment
    • King DL, Arendash GW, (2002) Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment. Brain Res. 1 926(1-2): 58-68.
    • (2002) Brain Res , vol.926 , Issue.1-2 , pp. 58-68
    • King, D.L.1    Arendash, G.W.2
  • 19
    • 0028267440 scopus 로고
    • Normal and abnormal biology of the beta-amyloid precursor protein
    • Selkoe DJ, (1994) Normal and abnormal biology of the beta-amyloid precursor protein. Annu Rev Neurosci. 17: 489-517.
    • (1994) Annu Rev Neurosci , vol.17 , pp. 489-517
    • Selkoe, D.J.1
  • 20
    • 0024362050 scopus 로고
    • Comparison of four staining methods on the detection of neuritic plaques
    • Wisniewski HM, Wen GY, Kim KS, (1989) Comparison of four staining methods on the detection of neuritic plaques. Acta Neuropathol. 78(1): 22-7.
    • (1989) Acta Neuropathol , vol.78 , Issue.1 , pp. 22-27
    • Wisniewski, H.M.1    Wen, G.Y.2    Kim, K.S.3
  • 21
    • 63849176138 scopus 로고    scopus 로고
    • The role of tau in neurodegeneration
    • Gendron TF, Petrucelli L, (2009) The role of tau in neurodegeneration. Mol Neurodegener. 11 4: 13.
    • (2009) Mol Neurodegener , vol.11 , Issue.4 , pp. 13
    • Gendron, T.F.1    Petrucelli, L.2
  • 22
    • 0028593606 scopus 로고
    • Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404
    • Otvos L Jr, Feiner L, Lang E, Szendrei GI, Goedert M, et al. (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res. 15 39(6): 669-73.
    • (1994) J Neurosci Res , vol.39 , Issue.6 , pp. 669-673
    • Otvos Jr., L.1    Feiner, L.2    Lang, E.3    Szendrei, G.I.4    Goedert, M.5
  • 23
    • 0029998294 scopus 로고    scopus 로고
    • Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation
    • Wagner U, Utton M, Gallo JM, Miller CC, (1996) Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. J Cell Sci. 109 (Pt 6): 1537-43.
    • (1996) J Cell Sci , vol.109 , Issue.Pt 6 , pp. 1537-1543
    • Wagner, U.1    Utton, M.2    Gallo, J.M.3    Miller, C.C.4
  • 24
    • 0034731461 scopus 로고    scopus 로고
    • Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice
    • Spittaels K, Van den Haute C, Van Dorpe J, Geerts H, Mercken M, et al. (2000) Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J Biol Chem. 29 275(52): 41340-9.
    • (2000) J Biol Chem , vol.275 , Issue.52 , pp. 41340-41349
    • Spittaels, K.1    van den Haute, C.2    Van Dorpe, J.3    Geerts, H.4    Mercken, M.5
  • 26
    • 77949491472 scopus 로고    scopus 로고
    • Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease
    • Rodríguez JJ, Witton J, Olabarria M, Noristani HN, Verkhratsky A, (2010) Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease. Cell Death Dis. 1(1): e1.
    • (2010) Cell Death Dis , vol.1 , Issue.1
    • Rodríguez, J.J.1    Witton, J.2    Olabarria, M.3    Noristani, H.N.4    Verkhratsky, A.5
  • 27
    • 0024824922 scopus 로고
    • Patterns of gliosis in Alzheimer's disease and aging cerebrum
    • Beach TG, Walker R, McGeer EG, (1989) Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia. 2(6): 420-36.
    • (1989) Glia , vol.2 , Issue.6 , pp. 420-436
    • Beach, T.G.1    Walker, R.2    McGeer, E.G.3
  • 29
    • 0042697305 scopus 로고    scopus 로고
    • Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction
    • Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, et al. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 31 39(3): 409-21.
    • (2003) Neuron , vol.39 , Issue.3 , pp. 409-421
    • Oddo, S.1    Caccamo, A.2    Shepherd, J.D.3    Murphy, M.P.4    Golde, T.E.5
  • 30
    • 27144511230 scopus 로고    scopus 로고
    • Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease
    • Buttini M, Masliah E, Barbour R, Grajeda H, Motter R, et al. (2005) Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease. J Neurosci. 5 25(40): 9096-101.
    • (2005) J Neurosci , vol.25 , Issue.40 , pp. 9096-9101
    • Buttini, M.1    Masliah, E.2    Barbour, R.3    Grajeda, H.4    Motter, R.5
  • 31
    • 78751644048 scopus 로고    scopus 로고
    • Amyloid-β and tau-a toxic pas de deux in Alzheimer's disease
    • Ittner LM, Götz J, (2011) Amyloid-β and tau-a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci. 12(2): 65-72.
    • (2011) Nat Rev Neurosci , vol.12 , Issue.2 , pp. 65-72
    • Ittner, L.M.1    Götz, J.2
  • 32
    • 73949142307 scopus 로고    scopus 로고
    • Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice
    • Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, et al. (2009) Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci U S A. 24 106(47): 20057-62.
    • (2009) Proc Natl Acad Sci U S A , vol.106 , Issue.47 , pp. 20057-20062
    • Rhein, V.1    Song, X.2    Wiesner, A.3    Ittner, L.M.4    Baysang, G.5
  • 33
    • 78650251838 scopus 로고    scopus 로고
    • Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration
    • Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, et al. (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron. 22 68(6): 1067-81.
    • (2010) Neuron , vol.68 , Issue.6 , pp. 1067-1081
    • Hoover, B.R.1    Reed, M.N.2    Su, J.3    Penrod, R.D.4    Kotilinek, L.A.5
  • 34
    • 34250818767 scopus 로고    scopus 로고
    • Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles
    • Caccamo A, Oddo S, Tran LX, LaFerla FM, (2007) Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. Am J Pathol. 170: 1669-1675.
    • (2007) Am J Pathol , vol.170 , pp. 1669-1675
    • Caccamo, A.1    Oddo, S.2    Tran, L.X.3    LaFerla, F.M.4
  • 35
    • 0032850599 scopus 로고    scopus 로고
    • Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes
    • Pei JJ, Braak E, Braak H, Grunde-Iqbal I, Iqbal K, et al. (1999) Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropath Exp Neurol 58, 1010-1019.
    • (1999) J Neuropath Exp Neurol , vol.58 , pp. 1010-1019
    • Pei, J.J.1    Braak, E.2    Braak, H.3    Grunde-Iqbal, I.4    Iqbal, K.5
  • 36
    • 0032590054 scopus 로고    scopus 로고
    • Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease
    • McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, et al. (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46, 860866.
    • (1999) Ann Neurol , vol.46 , pp. 860866
    • McLean, C.A.1    Cherny, R.A.2    Fraser, F.W.3    Fuller, S.J.4    Smith, M.J.5
  • 37
    • 25144501662 scopus 로고    scopus 로고
    • Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease
    • Gouras GK, Almeida CG, Takahashi RH (2005) Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 26, 1235-1244.
    • (2005) Neurobiol Aging , vol.26 , pp. 1235-1244
    • Gouras, G.K.1    Almeida, C.G.2    Takahashi, R.H.3
  • 39
    • 0036827031 scopus 로고    scopus 로고
    • Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology
    • Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, et al. (2002) Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161, 1869-1879.
    • (2002) Am J Pathol , vol.161 , pp. 1869-1879
    • Takahashi, R.H.1    Milner, T.A.2    Li, F.3    Nam, E.E.4    Edgar, M.A.5
  • 40
    • 33749521100 scopus 로고    scopus 로고
    • Intraneuronal beta amyloid aggregates neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation
    • Oakley H, Cole SL, Logan S, Maus E, Shao P, et al. (2006) Intraneuronal beta amyloid aggregates neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 26, 10129-10140.
    • (2006) J Neurosci , vol.26 , pp. 10129-10140
    • Oakley, H.1    Cole, S.L.2    Logan, S.3    Maus, E.4    Shao, P.5
  • 41
    • 78149488153 scopus 로고    scopus 로고
    • Amyloid-independent mechanisms in Alzheimer's disease pathogenesis
    • Pimplikar SW, Nixon RA, Robakis NK, Shen J, Tsai LH, (2010) Amyloid-independent mechanisms in Alzheimer's disease pathogenesis. J Neurosci. 2010 Nov 10 30(45): 14946-54.
    • (2010) J Neurosci , vol.30 , Issue.45 , pp. 14946-14954
    • Pimplikar, S.W.1    Nixon, R.A.2    Robakis, N.K.3    Shen, J.4    Tsai, L.H.5
  • 42
    • 33646133879 scopus 로고    scopus 로고
    • BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration
    • Yoon SY, Choi JE, Yoon JH, Huh JW, Kim DH, (2006) BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration. Neurobiol Dis. 22(2): 435-44.
    • (2006) Neurobiol Dis , vol.22 , Issue.2 , pp. 435-444
    • Yoon, S.Y.1    Choi, J.E.2    Yoon, J.H.3    Huh, J.W.4    Kim, D.H.5
  • 43
    • 33845324145 scopus 로고    scopus 로고
    • C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression
    • Kim HS, Kim EM, Lee JP, Park CH, Kim S, et al. (2003) C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. FASEB J. 17(13): 1951-3.
    • (2003) FASEB J , vol.17 , Issue.13 , pp. 1951-1953
    • Kim, H.S.1    Kim, E.M.2    Lee, J.P.3    Park, C.H.4    Kim, S.5
  • 44
    • 40249114794 scopus 로고    scopus 로고
    • Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing
    • Wen Y, Yu WH, Maloney B, Bailey J, Ma J, et al. (2008) Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron. 13 57(5): 680-90.
    • (2008) Neuron , vol.57 , Issue.5 , pp. 680-690
    • Wen, Y.1    Yu, W.H.2    Maloney, B.3    Bailey, J.4    Ma, J.5
  • 45
    • 0038187674 scopus 로고    scopus 로고
    • GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides
    • Phiel CJ, Wilson CA, Lee VM, Klein PS, (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature. 22 423(6938): 435-9.
    • (2003) Nature , vol.423 , Issue.6938 , pp. 435-439
    • Phiel, C.J.1    Wilson, C.A.2    Lee, V.M.3    Klein, P.S.4
  • 46
    • 34247187312 scopus 로고    scopus 로고
    • Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I
    • Flajolet M, He G, Heiman M, Lin A, Nairn AC, et al. (2007) Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I. Proc Natl Acad Sci U S A. 6. 104(10): 4159-64.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , Issue.10 , pp. 4159-4164
    • Flajolet, M.1    He, G.2    Heiman, M.3    Lin, A.4    Nairn, A.C.5
  • 47
    • 77953143687 scopus 로고    scopus 로고
    • Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy
    • Zotova E, Nicoll JA, Kalaria R, Holmes C, Boche D, (2010) Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alzheimers Res Ther. 22 2(1): 1.
    • (2010) Alzheimers Res Ther , vol.2 , Issue.1 , pp. 1
    • Zotova, E.1    Nicoll, J.A.2    Kalaria, R.3    Holmes, C.4    Boche, D.5
  • 48
    • 81955164821 scopus 로고    scopus 로고
    • Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice
    • Devi L, Ohno M, (2012) Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice. Neurobiol Dis. 45(1): 417-24.
    • (2012) Neurobiol Dis , vol.45 , Issue.1 , pp. 417-424
    • Devi, L.1    Ohno, M.2
  • 49
    • 4644230845 scopus 로고    scopus 로고
    • A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade
    • Dolev I, Michaelson DM, (2004) A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Proc Natl Acad Sci U S A 21 101(38): 13909-14.
    • (2004) Proc Natl Acad Sci U S A , vol.101 , Issue.38 , pp. 13909-13914
    • Dolev, I.1    Michaelson, D.M.2
  • 50
    • 44649090171 scopus 로고    scopus 로고
    • Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits
    • Belinson H, Lev D, Masliah E, Michaelson DM, (2008) Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits. J Neurosci. 30 28(18): 4690-701.
    • (2008) J Neurosci , vol.28 , Issue.18 , pp. 4690-4701
    • Belinson, H.1    Lev, D.2    Masliah, E.3    Michaelson, D.M.4
  • 51
    • 76149120867 scopus 로고    scopus 로고
    • Memantine improves cognition and reduces Alzheimer's like neuropathology in transgenic mice
    • Martinez-Coria M, Green KN, Billings LM, Kitazawa M, Albrecht M, (2010) Memantine improves cognition and reduces Alzheimer's like neuropathology in transgenic mice. Am J Pathol. 176(2): 870-80.
    • (2010) Am J Pathol , vol.176 , Issue.2 , pp. 870-880
    • Martinez-Coria, M.1    Green, K.N.2    Billings, L.M.3    Kitazawa, M.4    Albrecht, M.5
  • 52
    • 84864411864 scopus 로고    scopus 로고
    • Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD)
    • Filali M, Lalonde R, Theriault P, Julien C, Calon F, Planel E, (2012) Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD). Behav Brain Res. 1 234(2): 334-42.
    • (2012) Behav Brain Res , vol.234 , Issue.2 , pp. 334-342
    • Filali, M.1    Lalonde, R.2    Theriault, P.3    Julien, C.4    Calon, F.5    Planel, E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.